Effects of Ginkgo biloba in depression and cognitive problems of depressed patients treated with ECT referred to the psychiatric ward in Shahrekord Hajar hospital

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT138903192085N2

Enrollment

Registered

2010-06-09

Start date

2009-10-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depression. Depressive episode

Interventions

Intervention 1: Eight sessions of bilateral ECT, three times a week and placebo tablet for Ginkgo Biloba (every 8 hours) daily for 4 weeks. Intervention 2: Eight session of ECT 3 times a week and Gink

Placebo

Treatment - Drugs

Eight sessions of bilateral ECT, three times a week and placebo tablet for Ginkgo Biloba (every 8 hours) daily for 4 weeks

Eight session of ECT 3 times a week and Ginkgo Bilob, 40mg tablets, every 8 hours after meal for 4 weeks

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: suffering from the major depression, indication for treatment with ECT, scores more than 25 in Mini Mental State Exam Exclusion criteria: Psychotic disorders such as schizophrenia, schizoaffective, delirium, dementia, amnesia, consumption of anticoagulant drugs, treatment with other medicinal plants, Pregnancy

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Cognition and depression condition. Timepoint: before treatment, end of treatment, 4 weeks after begining the treatment. Method of measurement: Hamilton and Mini Mental State Exam questionnaire.	—

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026